Outset Medical, Inc.
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a OM research report →
Companywww.outsetmedical.com
Outset Medical, Inc. , a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings.
- CEO
- Leslie L. Trigg
- IPO
- 2020
- Employees
- 354
- HQ
- San Jose, CA, US
Price Chart
Valuation
- Market Cap
- $81.19M
- P/E
- -1.08
- P/S
- 0.69
- P/B
- 0.72
- EV/EBITDA
- -0.88
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 40.64%
- Op Margin
- -56.93%
- Net Margin
- -63.65%
- ROE
- -55.88%
- ROIC
- -31.33%
Growth & Income
- Revenue
- $119.48M · 5.09%
- Net Income
- $-81,653,000 · 36.20%
- EPS
- $-5.37 · 85.47%
- Op Income
- $-66,714,000
- FCF YoY
- 59.80%
Performance & Tape
- 52W High
- $21.98
- 52W Low
- $3.00
- 50D MA
- $3.97
- 200D MA
- $7.55
- Beta
- 1.91
- Avg Volume
- 177.67K
Get TickerSpark's AI analysis on OM
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Trigg Leslie | sell | 3,445 |
| May 15, 26 | Nash Marc | sell | 1,582 |
| May 15, 26 | Brottem John L. | sell | 2,638 |
| May 15, 26 | Leonard Braden Michael | other | 323,000 |
| May 11, 26 | Leonard Braden Michael | other | 96,900 |
| May 8, 26 | Leonard Braden Michael | other | 197,600 |
| Apr 6, 26 | Elliott Derick A. | other | 96,000 |
| Apr 6, 26 | Elliott Derick A. | other | 0 |
| Feb 12, 26 | Leonard Braden Michael | other | 617,500 |
| Feb 12, 26 | Leonard Braden Michael | other | 110,000 |
Our OM Coverage
We haven't published any research on OM yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate OM Report →